Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeting protein kinases involved in cancer cell proliferation. Shows potential in the synthesis of compounds with antitumor and anti-inflammatory activities. Also explored for its role in medicinal chemistry due to the quinoxaline core’s affinity for biological targets and the morpholine ring’s favorable pharmacokinetic properties. Investigated in the design of small-molecule therapeutics for oncology and central nervous system disorders.